Your browser doesn't support javascript.
loading
Association of amyloid angiopathy with microbleeds in logopenic progressive aphasia: an imaging-pathology study.
Buciuc, M; Duffy, J R; Machulda, M M; Spychalla, A J; Gunter, J L; Jack, C R; Giannini, C; Raghunathan, A; Dickson, D W; Josephs, K A; Whitwell, J L.
Afiliación
  • Buciuc M; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Duffy JR; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Machulda MM; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
  • Spychalla AJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Gunter JL; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Jack CR; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Giannini C; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Raghunathan A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Josephs KA; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Whitwell JL; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Eur J Neurol ; 28(2): 670-675, 2021 02.
Article en En | MEDLINE | ID: mdl-33068458
BACKGROUND AND PURPOSE: Cerebral microbleeds (MB) and superficial siderosis (SS) are frequent neuroimaging findings in patients with logopenic progressive aphasia (LPA), often with frontal lobe predilection. Cerebral amyloid angiopathy (CAA) is hypothesized to be the major pathologic determinant of MB/SS in these patients; however, neuroimaging-pathologic data are limited. METHODS: All patients who had been prospectively recruited by the Neurodegenerative Research Group at the Mayo Clinic (Rochester, MN) between 2010 and 2015 and met the following inclusion criteria were included: (i) received an antemortem LPA diagnosis, (ii) had a gradient-recalled echo T2*-weighted magnetic resonance imaging (MRI) performed, (iii) died and completed a brain autopsy. Demographic, genetic, neuroimaging, and clinical and pathologic characteristics were compared between patients with/without MB/SS. Two-tailed Fisher exact and Wilcoxon rank sum tests were used for comparison of categorical and continuous variables, respectively. RESULTS: Thirteen patients met inclusion criteria, six (46%) had MB/SS on MRI. Moderate/severe CAA was associated with the presence of MB/SS (p = 0.029). As expected, MB/SS most frequently involved the frontal lobes, followed by the parietal lobes. No clear associations were found between regional MB/SS distribution and regional distribution of CAA or hypometabolism on [18 F]-fluorodeoxyglucose-positron emission tomography. There was some evidence for a regional association between MB/SS and uptake on Pittsburgh compound B, although not in all patients. No formal statistical analyses to assess topographic relationships were performed due to the small sample size. CONCLUSIONS: The presence of MB/SS is a strong indicator of underlying moderate/severe CAA in LPA, although the biological mechanisms underlying the topographic distribution of MB/SS remain unclear.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Afasia / Angiopatía Amiloide Cerebral Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Afasia / Angiopatía Amiloide Cerebral Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos